Login / Signup

Digital nature: Unveiling the impact and safety of FlowVR group intervention for depression in a feasibility trial.

Franziska Sophia MiegelLuzie LohseLena JelinekJakob ScheunemannTana GabbertGesche SchauenburgLukas BittnerFariba MostajeranSimone KühnJürgen GallinatAmir Yassari
Published in: Acta psychiatrica Scandinavica (2024)
To conclude, FlowVR had the hypothesized positive impact over the course of the sessions, showing, for example, improvements in symptomatology. The sessions have demonstrated safety with no notable deteriorations. Therefore, FlowVR is deemed safe for clinical patients and group settings. However, further research is needed to explore predictors for the change in depression.
Keyphrases
  • end stage renal disease
  • depressive symptoms
  • newly diagnosed
  • randomized controlled trial
  • ejection fraction
  • chronic kidney disease
  • sleep quality
  • study protocol
  • prognostic factors